Cryo Balloon for Residual Barrett's Esophagus

Overview

About this study

To assess the response of persistent Barrett's Esophagus and/or dysplasia to focal cyro ablation .

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Eligible patients for enrollment in this study must fulfill all of the following criteria:

  • Age > 18 years old
  • Able to provide informed consent
  • Patients with unifocal or multifocal BE with 2 cm who have failed at least 2 serial RFA or other endoscopic therapy such as Endoscopic Mucosal resection,

Exclusion from the study with any of the following:

  • Age younger than 18 years old
  • Presence of esophageal varices
  • Esophageal stricture precluding passage of an endoscope
  • Inability to provide informed consent
  • Esophageal cancer (T2 and above)
  • Coagulopathy with INR > 2.0, thrombocytopenia with platelet counts < 50,000
  • pregnancy (if required a pregnancy test would be performed as part of routine clinical care)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Kenneth Wang, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20133918

Mayo Clinic Footer